Polymyalgia Rheumatica

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-11-20
Clinical Trial Update: Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of sirukumab in polymyalgia rheumatica was withdrawn by the sponsor.